Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine.

Suppr

超能文献

作者信息

Wu Xiaotian, Lim Joel Hua Liang, Lee Joyce Siong See, Chio Martin Tze-Wei

机构信息

National Skin Centre, Singapore, Singapore.

出版信息

JAAD Int. 2022 Mar;6:107-108. doi: 10.1016/j.jdin.2021.12.009. Epub 2021 Dec 28.

DOI:10.1016/j.jdin.2021.12.009

PMID:34977819

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8712276/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/101e/8819018/0a9d3535a421/gr1.jpg

相似文献

Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine.

JAAD Int. 2022 Mar;6:107-108. doi: 10.1016/j.jdin.2021.12.009. Epub 2021 Dec 28.

Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine.

Med Arch. 2022 Feb;76(1):72-74. doi: 10.5455/medarh.2022.76.72-74.

Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.

Vaccines (Basel). 2021 Nov 9;9(11):1297. doi: 10.3390/vaccines9111297.

Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.

JAMA Netw Open. 2021 Aug 2;4(8):e2122255. doi: 10.1001/jamanetworkopen.2021.22255.

Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.

MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1761-1765. doi: 10.15585/mmwr.mm705152a2.

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.

MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1579-1583. doi: 10.15585/mmwr.mm7045e1.

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.

MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):749-752. doi: 10.15585/mmwr.mm7020e1.

Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.

MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1344-1348. doi: 10.15585/mmwr.mm7038e2.

COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.

MMWR Morb Mortal Wkly Rep. 2021 Aug 6;70(31):1053-1058. doi: 10.15585/mmwr.mm7031e1.

Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine.

J Pediatric Infect Dis Soc. 2021 Nov 11;10(10):962-966. doi: 10.1093/jpids/piab060.

引用本文的文献

Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.

J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.

Manifestation of a cancer-associated TIF-1 gamma dermatomyositis after COVID-19 vaccine.

Int J Dermatol. 2022 Nov;61(11):1425-1426. doi: 10.1111/ijd.16358. Epub 2022 Jul 14.

Covid-19 vaccine associated erythema nodosum: Factors to consider.

Dermatol Ther. 2022 May;35(5):e15410. doi: 10.1111/dth.15410. Epub 2022 Mar 9.

本文引用的文献

COVID-19 vaccine BNT162b1 elicits human antibody and T1 T cell responses.

Nature. 2020 Oct;586(7830):594-599. doi: 10.1038/s41586-020-2814-7. Epub 2020 Sep 30.

The ASIA syndrome: basic concepts.

Mediterr J Rheumatol. 2017 Jun 27;28(2):64-69. doi: 10.31138/mjr.28.2.64. eCollection 2017 Jun.

TNF-alpha in tuberculosis: a cytokine with a split personality.

Inflamm Allergy Drug Targets. 2009 Mar;8(1):53-62. doi: 10.2174/187152809787582543.

Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum.

Acta Derm Venereol. 2001 Jan-Feb;81(1):18-21. doi: 10.1080/00015550116912.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验